MedTrace Logo

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

NCT03521596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-11-18

No results posted yet for this study

Summary

Multicenter retrospective and prospective observational study including patients with WM or IgM-MGUS evaluated at the time of diagnosis and during the disease course using highly sensitive techniques.

Conditions

Interventions

OTHER

MRD and clonal evolution

Patient evaluation at the time of diagnosis and during the disease course using highly sensitive techniques

Sponsors & Collaborators

  • Fondazione Italiana Linfomi - ETS

    lead OTHER

Principal Investigators

  • Marzia Varettoni · Pavia - IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-28
Primary Completion
2020-10-06
Completion
2025-10-02

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03521596 on ClinicalTrials.gov